November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
November 2, 2024 Tech Titans’ Mixed Results Stall Wall Street Bull Run
October 28, 2024 Recent Oil Slides In Global Markets, Japan In Flux
Tesla’s Valuation: Unsupported By Fundamentals Or Future Growth
Tesla Stock Doesn’t Deserve This Rally
Nvidia: Q3 Earnings Could Ignite $200 Rally
Tesla: When Fundamentals Don’t Matter (Rating Downgrade)
Amazon Q3: Stop Buying The Stock For Now Because It’s Overvalued
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Agilent Technologies (A) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: November 14, 2024 (09:31)
Sector: HealthcareThe share price of Agilent Technologies, Inc. (A) now
Analysts predictions
Full report
This Week
|
Neutral | Opinions: Na |
Previous Week
|
Neutral | Opinions: Na |
Two Weeks Ago
|
Neutral | Opinions: Na |
Three Weeks Ago
|
Neutral | Opinions: Na |
Are you interested in Agilent Technologies, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Agilent Technologies stock price in 2024, 2025, 2026. How much will one Agilent Technologies share be worth in 2024 - 2026?
When should I take profit in Agilent Technologies stock? When should I record a loss on Agilent Technologies stock? What are analysts' forecasts for Agilent Technologies stock? What is the future of Agilent Technologies stock? We forecast Agilent Technologies stock performance using neural networks based on historical data on Agilent Technologies stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Agilent Technologies stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Agilent Technologies shares. This happens once a day.
Historical and forecast chart of Agilent Technologies stock
The chart below shows the historical price of Agilent Technologies stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Agilent Technologies stock price can be found in the table below.
Long-term forecasts by years.
Agilent Technologies, Inc. Analysts predictions review
As of now, Panda has combed through 0 analytical articles which are directly related to A from the last 30 days. Out of these, 0 clearly showcase a bullish trend, while 0 see a bearish trend as the more likely scenario, and 0 stay neutral.
To identify the dominant trend, we took into account analytical articles from the past 30 days, spanning from Jan 01, 1970 to Jan 01, 1970.
Agilent Technologies: A Strategic Buy Amidst Growing Biopharma, PFAS Advances, and Semiconductor Expansion
Hunter Wolf Research has crafted a compelling and well-informed analysis emphasizing a bullish outlook on A stock. The author, contributing since 2015, has consistently showcased a keen financial insight, solidified by the publication of 100 articles. With 1,455 subscribers following these insights, the author's perspectives carry substantial weight in the financial community. The high volume of work over their tenure indicates a dedicated and prolific analysis production, further enhancing their credibility. Given the author's solid standing, readers can approach this review with confidence, knowing it comes from a highly regarded source in financial analytics.
Key Theses of the Review
- Agilent Technologies focuses on growing biopharma, PFAS testing, and advanced materials for semiconductors.
- Recent acquisitions and divestitures show mixed results, with potential for technological enhancement but concerns about fit in the portfolio.
- Despite challenges in the pharma market, Agilent's diversified revenue streams and potential for growth in key areas make it a 'Buy' with a target price of $160 per share.
Factors Influencing Agilent's Stock Price
PFAS Testing Market
The new regulations and funding for PFAS testing and treatment are expected to positively impact Agilent's workflow solution dedicated to PFAS testing and reporting, driving growth. In Q3 FY24, the Environmental & Forensics segment grew by 4% due to increasing PFAS testing workflows.
Semiconductor Testing Market
Agilent's strong market share in advanced materials for semiconductors places it well to capture growth from increasing geopolitical demand for domestic semiconductor fabs. The rapid growth in AI, EV, and factory automation further drives the semiconductor market's expansion potential.
Pharma and Biotech Market
The pharma business faced a significant decline of 8% year-over-year due to current high-interest rates and weak private equity funding. However, anticipations of market recovery later in FY25 could bolster Agilent's recurring business in the pharma sector.
Recent Acquisitions and Divestitures
The mixed outcomes of recent acquisitions, such as the divestiture of Resolution Bioscience and the acquisition of BIOVECTRA, present concerns regarding their fit with Agilent's portfolio. The small strategic acquisition of Sigsense to enhance technological capabilities shows potential but needs further assessment for substantial impact.
China Market Exposure
China accounts for more than 34% of Agilent's total revenue, and the 11% decline in this region in Q3 FY24 highlights the risks posed by China's weak economic growth. Given the current indications, a swift recovery in the biopharma industry in China seems unlikely.
Environmental Regulations
The potential FDA regulations for PFAS-free products could expand Agilent's addressable market from just water to the food industry. This regulatory landscape is expected to drive further demand for Agilent's testing products in the near future.
Review the original AnalysisAgilent Technologies is an American manufacturer of measuring, electronic medical and chemical biological equipment. Most of the company’s product lines were developed by Hewlett-Packard, an American company founded in 1939. Agilent maintains a central R&D team at Agilent Laboratories, which conducts research in areas such as MEMS, nanotechnology, and biochemistry.
Agilent Technologies daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Nov 16 | 133.57 | 132.59 | 134.54 | 1.47 |
Nov 17 | 133.85 | 133.34 | 134.91 | 1.17 |
Nov 18 | 134.39 | 134.01 | 134.68 | 0.50 |
Nov 19 | 133.08 | 132.47 | 133.57 | 0.83 |
Nov 20 | 134.07 | 133.73 | 134.88 | 0.86 |
Nov 21 | 133.92 | 132.92 | 134.29 | 1.04 |
Nov 22 | 133.96 | 133.30 | 134.70 | 1.04 |
Nov 23 | 134.01 | 133.22 | 134.94 | 1.29 |
Nov 24 | 134.46 | 134.12 | 134.91 | 0.59 |
Nov 25 | 134.81 | 134.01 | 135.29 | 0.96 |
Nov 26 | 134.70 | 133.74 | 135.34 | 1.20 |
Nov 27 | 135.57 | 135.00 | 136.18 | 0.87 |
Nov 28 | 135.40 | 134.39 | 135.98 | 1.18 |
Nov 29 | 134.96 | 133.92 | 135.96 | 1.52 |
Nov 30 | 134.48 | 133.40 | 135.24 | 1.38 |
Dec 01 | 135.30 | 134.88 | 136.16 | 0.95 |
Dec 02 | 135.12 | 134.66 | 135.54 | 0.65 |
Dec 03 | 135.35 | 134.85 | 136.06 | 0.89 |
Dec 04 | 135.69 | 134.63 | 136.53 | 1.41 |
Dec 05 | 136.23 | 135.69 | 136.55 | 0.63 |
Dec 06 | 136.61 | 136.01 | 137.60 | 1.17 |
Dec 07 | 135.67 | 134.87 | 136.31 | 1.07 |
Dec 08 | 136.31 | 135.49 | 137.07 | 1.17 |
Dec 09 | 135.63 | 135.33 | 136.36 | 0.76 |
Dec 10 | 136.22 | 135.37 | 137.07 | 1.26 |
Dec 11 | 136.80 | 135.74 | 137.88 | 1.57 |
Dec 12 | 135.61 | 135.20 | 136.68 | 1.09 |
Dec 13 | 136.27 | 135.55 | 137.09 | 1.14 |
Dec 14 | 135.02 | 134.00 | 135.84 | 1.37 |
Dec 15 | 134.17 | 133.64 | 135.16 | 1.13 |
Agilent Technologies Daily Price Targets
Agilent Technologies Stock Forecast 11-16-2024.
Forecast target price for 11-16-2024: $133.57.
Negative dynamics for Agilent Technologies shares will prevail with possible volatility of 1.449%.
Pessimistic target level: 132.59
Optimistic target level: 134.54
Agilent Technologies Stock Forecast 11-17-2024.
Forecast target price for 11-17-2024: $133.85.
Positive dynamics for Agilent Technologies shares will prevail with possible volatility of 1.161%.
Pessimistic target level: 133.34
Optimistic target level: 134.91
Agilent Technologies Stock Forecast 11-18-2024.
Forecast target price for 11-18-2024: $134.39.
Positive dynamics for Agilent Technologies shares will prevail with possible volatility of 0.499%.
Pessimistic target level: 134.01
Optimistic target level: 134.68
Agilent Technologies Stock Forecast 11-19-2024.
Forecast target price for 11-19-2024: $133.08.
Negative dynamics for Agilent Technologies shares will prevail with possible volatility of 0.827%.
Pessimistic target level: 132.47
Optimistic target level: 133.57
Agilent Technologies Stock Forecast 11-20-2024.
Forecast target price for 11-20-2024: $134.07.
Positive dynamics for Agilent Technologies shares will prevail with possible volatility of 0.855%.
Pessimistic target level: 133.73
Optimistic target level: 134.88
Agilent Technologies Stock Forecast 11-21-2024.
Forecast target price for 11-21-2024: $133.92.
Negative dynamics for Agilent Technologies shares will prevail with possible volatility of 1.027%.
Pessimistic target level: 132.92
Optimistic target level: 134.29
A (A) Monthly Stock Prediction for 2024
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Dec. | 136.48 | 131.09 | 140.16 | 6.48 |
Agilent Technologies forecast for this year
Agilent Technologies Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $136.477. Pessimistic: $131.09. Optimistic: $140.16
Agilent Technologies (A) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 138.59 | 135.82 | 141.02 | 3.69 |
Feb | 138.04 | 133.90 | 142.46 | 6.01 |
Mar | 141.21 | 136.84 | 145.17 | 5.74 |
Apr | 141.28 | 138.03 | 142.70 | 3.27 |
May | 145.17 | 141.39 | 147.64 | 4.23 |
Jun | 142.48 | 138.85 | 147.97 | 6.16 |
Jul | 142.41 | 137.36 | 147.82 | 7.08 |
Aug | 141.91 | 139.50 | 146.17 | 4.56 |
Sep | 147.16 | 142.23 | 150.18 | 5.29 |
Oct | 144.15 | 139.54 | 148.33 | 5.93 |
Nov | 145.52 | 140.72 | 147.77 | 4.78 |
Dec | 149.52 | 147.13 | 153.33 | 4.05 |
Agilent Technologies (A) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 147.35 | 142.05 | 149.12 | 4.74 |
Feb | 152.51 | 148.47 | 155.41 | 4.47 |
Mar | 154.80 | 149.84 | 158.98 | 5.74 |
Apr | 161.22 | 159.37 | 167.02 | 4.58 |
May | 169.28 | 163.02 | 174.44 | 6.55 |
Jun | 169.45 | 162.76 | 175.55 | 7.29 |
Jul | 161.57 | 155.84 | 165.93 | 6.09 |
Aug | 161.49 | 158.02 | 164.72 | 4.07 |
Sep | 162.86 | 156.84 | 165.47 | 5.22 |
Oct | 164.57 | 160.38 | 169.59 | 5.43 |
Nov | 162.35 | 156.34 | 168.85 | 7.40 |
Dec | 164.06 | 159.30 | 167.91 | 5.13 |
Agilent Technologies information and performance
5301 STEVENS CREEK BLVD, SANTA CLARA, CA, US
Market capitalization of the Agilent Technologies, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of A shares in the company outstanding by the market price of one share.
EBITDA of Agilent Technologies is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Agilent Technologies (A) stock dividend
Agilent Technologies last paid dividends on 10/01/2024. The next scheduled payment will be on 10/23/2024. The amount of dividends is $0.933 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.
Commentary
Agilent Technologies is poised for growth, with bright prospects in the biopharma, PFAS, and semiconductor markets. The diverse drivers—ranging from new regulations in PFAS testing to the growing demand for advanced semiconductor materials—demonstrate strong potential across multiple segments. These factors, collectively, reflect significant positive pressures on Agilent's stock. On average, these influences are moderately strong, especially given the high significance attributed to PFAS testing and semiconductor markets.
In the next 15 days, the stock is expected to see steady gains as the market factors in regulatory and market-driven growth. Over the coming month, the average influence might see heightened volatility from factors such as China's economic exposure and recovery expectations in the pharma sector. Despite mixed outcomes from acquisitions and divestitures, Agilent's diversified revenue streams and strategic focus keep its stock forecast bullish with a target price of $160.